Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.

Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.

Item
http://www.wikidata.org/entity/Q34571360
Towards a rational design of solid drug nanoparticles with optimised pharmacological properties.Pharmacokinetics of metallic nanoparticles.Polymeric nanoparticles: the future of nanomedicine.Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment.Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate.The therapeutic landscape of HIV-1 via genome editingSpecial issue of BJP on nanomedicine.Natural Nanoparticles: A Particular Matter Inspired by Nature.The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery.Internal Targeting and External Control: Phototriggered Targeting in Nanomedicine.Characterisation, in-vitro and in-vivo evaluation of valproic acid-loaded nanoemulsion for improved brain bioavailability.
P2860

Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.

Item
http://www.wikidata.org/entity/Q34571360
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@ast
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@en
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@nl
type
label
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@ast
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@en
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@nl
prefLabel
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@ast
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@en
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@nl
P1433
P1476
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Optimizing nanomedicine pharma ...... ed pharmacokinetics modelling.
@en
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932